The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of blinded, single ascending oral doses of ABT 072 under non-fasting conditions in healthy adult Japanese male subjects.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
24
Unnamed facility
Kagoshima, Prefecture, Japan
Safety and tolerability assessment
Safety and tolerability assessment by the evaluation of vital signs, ECGs, physical exams, clinical lab testing and adverse event monitoring.
Time frame: Day 1 to Day 4 and Day 15.
Pharmacokinetic profile evaluation
Single Dose Pharmacokinetic profile evaluation
Time frame: Day 1 to Day 4
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.